A Review of Pharmacokinetic Drug–Drug Interactions with the Anthelmintic Medications Albendazole and Mebendazole
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Medications indicated for helminthes and other parasitic infections are frequently being used in mass populations in endemic areas. Currently, there is a lack of guidance for clinicians on how to appropriately manage drug interactions when faced with patients requiring short-term anthelmintic therapy with albendazole or mebendazole while concurrently taking other agents. The objective of this review was to systematically summarize and evaluate published literature on the pharmacokinetics of albendazole or mebendazole when taken with other interacting medications. A search of MEDLINE (1946 to October 2014), EMBASE (1974 to October 2014), International Pharmaceutical Abstracts (1970 to October 2014), Google, and Google Scholar was conducted for articles describing the pharmacokinetics of albendazole or mebendazole when given with other medications (and supplemented by a bibliographic review of all relevant articles). Altogether, 17 articles were included in the review. Studies reported data on pharmacokinetic parameters for albendazole or mebendazole when taken with cimetidine, dexamethasone, ritonavir, phenytoin, carbamazepine, phenobarbital, ivermectin, praziquantel, diethylcarbamazine, azithromycin, and levamisole. Cimetidine increased the elimination half-life of albendazole and maximum concentration (Cmax) of mebendazole; dexamethasone increased the area under the plasma concentration-time curve (AUC) of albendazole; levamisole decreased the Cmax of albendazole; anticonvul…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Inhibition and Induction of Cytochrome P450 and the Clinical Implications
Lin, J. H., & Lu, A. Y. H. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835050-00003 · Cited by 829
Feasey, N., Wansbrough-Jones, M., Mabey, D. C. W., & Solomon, A. W. (2010) · British Medical Bulletin · doi:10.1093/bmb/ldp046 · Cited by 817
Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics
Dayan, A. D. (2003) · Acta Tropica · doi:10.1016/s0001-706x(03)00031-7 · Cited by 371
Li, X.-Q., Bj�rkman, A., Andersson, T. B., Gustafsson, L. L., & Masimirembwa, C. M. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0636-9 · Cited by 232
Mass drug treatment for lymphatic filariasis and onchocerciasis
Molyneux, D. H., Bradley, M., Hoerauf, A., Kyelem, D., & Taylor, M. J. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.09.004 · Cited by 220
Yeh, R. F., Gaver, V. E., Patterson, K. B., Rezk, N. L., Baxter-Meheux, F., Blake, M. J., Eron, J. J., Klein, C. E., Rublein, J. C., & Kashuba, A. D. M. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000219774.20174.64 · Cited by 194
The metabolism of benzimidazole anthelmintics
Gottschall, D. W., Theodorides, V. J., & Wang, R. (1990) · Parasitology Today · doi:10.1016/0169-4758(90)90228-v · Cited by 172
Pharmacokinetic Interactions Between Antiepileptic Drugs: Clinical Considerations
Riva, R., Albani, F., Contin, M., & Baruzzi, A. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631060-00005 · Cited by 171
In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone
McCune, J. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.110215 · Cited by 162
Jung, H., Medina, L., García, L., Fuentes, I., & Moreno-Esparza, R. (1998) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1998.tb03303.x · Cited by 137
Research works printed but not linked: 2
- Li X-Q, Björkman A, Andersson TB, Gustafsson LL, Masimirembwa CM. Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data. Eur J Clin Pharmacol. 2003;59:429–42. · DOI · Paper page
- Lin JH, Lu AYH. Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet. 1998;35:361–90. · DOI · Paper page
Cited by
Soil-transmitted helminth infections
Jourdan, P. M., Lamberton, P. H. L., Fenwick, A., & Addiss, D. G. (2018) · The Lancet · doi:10.1016/s0140-6736(17)31930-x · Cited by 994
Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update
Chai, J.-Y., Jung, B.-K., & Hong, S.-J. (2021) · The Korean Journal of Parasitology · doi:10.3347/kjp.2021.59.3.189 · Cited by 286
Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles
Wordeman, L., & Vicente, J. J. (2021) · Cancers · doi:10.3390/cancers13225650 · Cited by 167
The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs
Son, D.-S., Lee, E.-S., & Adunyah, S. E. (2020) · Immune Network · doi:10.4110/in.2020.20.e29 · Cited by 130
Paediatric schistosomiasis: What we know and what we need to know
Osakunor, D. N. M., Woolhouse, M. E. J., & Mutapi, F. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006144 · Cited by 121
Metadata
- Authors
- Pawluk, S. A., Roels, C. A., Wilby, K. J., & Ensom, M. H. H.
- Affiliations
- Qatar University (QA)
- University of British Columbia (CA)
- Corresponding author
- Pawluk, Shane Ashley
- Venue
- Clinical Pharmacokinetics
- Published
- 2015-02-18
- Volume
- 54
- Issue
- 4
- Pages
- 371-383
- ISSN
- 0312-5963 (ISSN-L)
- 1179-1926
- OpenAlex
- W2050422640
- Semantic Scholar
- 0fd5823061f7a87b0d9ad9d3906a7c1c6bac3b72
- Cited by
- 59
- References
- 44
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 1 · 2023: 7 · 2022: 8 · 2021: 8 · 2020: 5 · 2019: 7 · 2018: 9 · 2017: 2 · 2016: 4 · 2015: 1
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Clinical Pharmacokinetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- World Health Organization
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Keywords
- albendazole, mebendazole, anthelmintics, drug-drug interactions, pharmacokinetics, cimetidine, dexamethasone, ritonavir, antiepileptic drugs, phenytoin, phenobarbital, carbamazepine, levamisole, praziquantel, ivermectin, azithromycin, diethylcarbamazine, helminthiasis, parasitic infection
- MeSH terms
- Adult, Anthelmintics, Child, Child, Preschool, Drug Interactions, Drug Therapy, Combination, Female, Humans, Male, Mebendazole, Albendazole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Review of Pharmacokinetic Drug–Drug Interactions with the Anthelmintic Medications Albendazole and Mebendazole. https://app.cochat.ai/papers/10.1007/s40262-015-0243-9
- The paper
- Pawluk, S. A., Roels, C. A., Wilby, K. J., & Ensom, M. H. H. (2015). A Review of Pharmacokinetic Drug–Drug Interactions with the Anthelmintic Medications Albendazole and Mebendazole. Clinical Pharmacokinetics. https://doi.org/10.1007/s40262-015-0243-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.